Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T22:48:51.492Z.
Calculation as of: 2026-10-06T22:48:51.492Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 08a81e5feebad721ee05cca7d6a51b618a8c436619bf2c78a545ff1cd4f886dd
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
Jin Medical International Ltd.
Market Cap
$15.58M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.68M
EV/Sales Ratio
60.81x
TTM Avg
56.79x
3Y Avg
56.79x
5Y Avg
56.79x
Market Cap
$15.78M
EV/Sales Ratio
N/A
TTM Avg
492.25x
3Y Avg
202.04x
5Y Avg
285.29x
Market Cap
$15.30M
EV/Sales Ratio
43.87x
TTM Avg
46.98x
3Y Avg
46.98x
5Y Avg
36.15x
Market Cap
$14.94M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.73M
EV/Sales Ratio
1.20x
TTM Avg
1.84x
3Y Avg
1.65x
5Y Avg
2.08x
Market Cap
$16.52M
EV/Sales Ratio
5.80x
TTM Avg
10.55x
3Y Avg
12.56x
5Y Avg
17.17x
Market Cap
$16.64M
EV/Sales Ratio
0.65x
TTM Avg
0.67x
3Y Avg
1.03x
5Y Avg
10.93x
Market Cap
$14.46M
EV/Sales Ratio
50.78x
TTM Avg
16.53x
3Y Avg
4.93x
5Y Avg
3.45x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jin Medical International Ltd. (ZJYL) | $15.58M | N/A | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.68M | 60.81x | 56.79x | 56.79x | 56.79x |
| BioCardia, Inc. (BCDA)vs › | $15.78M | N/A | 492.25x | 202.04x | 285.29x |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | 43.87x | 46.98x | 46.98x | 36.15x |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.94M | N/A | N/A | N/A | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.73M | 1.20x | 1.84x | 1.65x | 2.08x |
| Dyadic International, Inc. (DYAI)vs › | $16.52M | 5.80x | 10.55x | 12.56x | 17.17x |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | 0.65x | 0.67x | 1.03x | 10.93x |
| Vyome Holdings, Inc. (HIND)vs › | $14.46M | 50.78x | 16.53x | 4.93x | 3.45x |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | 0.72x | 1.08x | 179.64x | 2065.58x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
